USP7 and cancer: The lack of impact of USP7 inhibition on sVEGF in epithelial cancer cells was not due to a lack of target engagement as AD‐04 demonstrated potent target engagement in both primary fibroblasts and cancer cells (assessed using ubiquitin activity‐based probe competition assays26; Figure S2).